Shanghai Minwei Biotechnology Co., Ltd clinical trials

Acquired by Lepu Medical, Feb 8, 2024 · source ↗

The registry lists 21 studies whose lead sponsor is Shanghai Minwei Biotechnology Co., Ltd. 10 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 17, 2026.

Studies

Recruiting first, then most recently updated. Showing 21 of 21. All Lepu Medical studies →

• Phase 1 Clinical Study of MWN117 Injection in Healthy Participants and Participants With ObesityNot yet recruitingNCT07824804Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes MellitusRecruitingNCT07801820Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 2 Clinical Study of MWX203 Injection Alone or in Combination With Inclisiran Sodium Injection in Patients With Mixed DyslipidemiaRecruitingNCT07803822Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or ObesityRecruitingNCT07803809Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild HypertensionRecruitingNCT07803835Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese ParticipantsNot yet recruitingNCT07779980Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 3 Study of MWN109 Injection in Participants With Overweight or ObesityNot yet recruitingNCT07778693Phase 3

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205Not yet recruitingNCT07634510Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• A Study to Evaluate MWN109 Tablets in Healthy Adult ParticipantsRecruitingNCT06938269Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• A Study to Evaluate MWN109 Injection in Healthy SubjectsRecruitingNCT06859853Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 2 Clinical Study of MWN105 Injection in Participants With Overweight or ObesityCompletedNCT07804810Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or ObesityActive, not recruitingNCT07804797Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWN105 Injection in Healthy Chinese VolunteersCompletedNCT07801313Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• A Study to Evaluate Different Administration Conditions and the Food Effect of MWN109 Tablets in Chinese ParticipantsCompletedNCT07801326Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWX203 Injection in Healthy SubjectsActive, not recruitingNCT07799025Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or ObesityCompletedNCT07787728Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 2 Study of MWN109 Tablet in Participants With Overweight or ObesityCompletedNCT07791524Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or ObesityCompletedNCT07791654Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With OverweightActive, not recruitingNCT07791537Phase 2

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase I Clinical Study of MWN109 Tablets in Healthy Chinese ParticipantsCompletedNCT07787611Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical

• Phase 1 Clinical Study of MWN109 Injection in Healthy Chinese VolunteersCompletedNCT07787624Phase 1

  Sponsor listed in the registry: Shanghai Minwei Biotechnology Co., Ltd · First submitted after Shanghai Minwei Biotechnology Co., Ltd became part of Lepu Medical